Why it matters: Novo has struggled to stay competitive with Eli Lilly LLY in developing the next generation of obesity drugs that could improve on Lillys Zepbound, with disappointing data for phase 2 drug monlunabant in September and phase 3 GLP-1 and amylin combination cagrisema in December
Results: GLP-1 receptors were detected in smooth muscle nuclei and enteric ganglia, while GIP receptors localized to both muscle layers
Social media activity spiked following celebrity endorsements, regulatory approvals, the FDA pediatric approval, and media attention, revealing how external events influence public discourse
Conclusion: Is Glutathione Right for You
Many specialized compounds are currently available from NewBioRx, some of which are not widely offered by other peptide suppliers
Some peoples bodies respond better to one over the other, and some may experience side effects on one but not the other